Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Docetaxel and Trastuzumab with or without Carboplatin in HER2-Positive Advanced Breast Cancer
NCT00047255Phase 3Completed
- Sponsor
- UCLA Jonsson Comprehensive Cancer Center
- Start
- May 2002
- Primary completion
- Jan 2006
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 3 trial of carboplatin in breast cancer, sponsored by UCLA Jonsson Comprehensive Cancer Center. Started May 2002; status: completed.
02
Drugs
carboplatin
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00047255.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00047255.